DK1052973T3 - Transmucosale formuleringer af levosimendan - Google Patents

Transmucosale formuleringer af levosimendan

Info

Publication number
DK1052973T3
DK1052973T3 DK98959930T DK98959930T DK1052973T3 DK 1052973 T3 DK1052973 T3 DK 1052973T3 DK 98959930 T DK98959930 T DK 98959930T DK 98959930 T DK98959930 T DK 98959930T DK 1052973 T3 DK1052973 T3 DK 1052973T3
Authority
DK
Denmark
Prior art keywords
levosimendan
patient
source
mucous membrane
transmucosal formulations
Prior art date
Application number
DK98959930T
Other languages
Danish (da)
English (en)
Inventor
Kauko Kurkela
Martti Marvola
Ilkka Larma
Raimo Virtanen
Marianne Karlsson
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Application granted granted Critical
Publication of DK1052973T3 publication Critical patent/DK1052973T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Physiology (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Paper (AREA)
  • Air Bags (AREA)
DK98959930T 1997-12-19 1998-12-11 Transmucosale formuleringer af levosimendan DK1052973T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI974578A FI974578A (fi) 1997-12-19 1997-12-19 Menetelmä levosimendaanin antamiseksi
PCT/FI1998/000977 WO1999032081A1 (en) 1997-12-19 1998-12-11 Transmucosal formulations of levosimendan

Publications (1)

Publication Number Publication Date
DK1052973T3 true DK1052973T3 (da) 2002-04-29

Family

ID=8550178

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98959930T DK1052973T3 (da) 1997-12-19 1998-12-11 Transmucosale formuleringer af levosimendan

Country Status (26)

Country Link
US (1) US6399610B1 (sh)
EP (1) EP1052973B1 (sh)
JP (1) JP2001526205A (sh)
KR (1) KR100753689B1 (sh)
AT (1) ATE215358T1 (sh)
AU (1) AU738082B2 (sh)
BR (1) BR9813641A (sh)
CA (1) CA2313618C (sh)
CZ (1) CZ296693B6 (sh)
DE (1) DE69804678T2 (sh)
DK (1) DK1052973T3 (sh)
EA (1) EA002197B1 (sh)
EE (1) EE04330B1 (sh)
ES (1) ES2175827T3 (sh)
FI (1) FI974578A (sh)
HR (1) HRP20000400B1 (sh)
HU (1) HU226736B1 (sh)
IL (1) IL136415A (sh)
NO (1) NO320050B1 (sh)
NZ (1) NZ504806A (sh)
PL (1) PL191868B1 (sh)
PT (1) PT1052973E (sh)
RS (1) RS49889B (sh)
SK (1) SK284838B6 (sh)
WO (1) WO1999032081A1 (sh)
ZA (1) ZA9811405B (sh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI980901A (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaania säädellysti vapauttavia oraalisia koostumuksia
FI20002755A0 (fi) 2000-12-15 2000-12-15 Orion Yhtymae Oyj Menetelmä erektiilin dysfunktion hoitamiseen
CN100428937C (zh) * 2003-10-30 2008-10-29 北京海合天科技开发有限公司 左西孟旦冷冻干燥组合物
FI20040674A0 (fi) 2004-05-12 2004-05-12 Orion Corp Menetelmä tromboembolisten sairauksien estoon
AU2006214166B2 (en) * 2005-02-17 2011-09-29 Zoetis Belgium S.A. Transmucosal administration of drug compositions for treating and preventing disorders in animals
CA2596768A1 (en) * 2005-02-18 2006-08-24 Orion Corporation A method for treating heart failure
WO2007096906A2 (en) * 2006-02-27 2007-08-30 Panacea Biotec Ltd. Novel buccoadhesive compositions and process of preparation thereof
WO2008037470A1 (en) * 2006-09-27 2008-04-03 Niconovum Ab Directional use
US20220160656A1 (en) * 2019-03-22 2022-05-26 Dbbh, Llc Intranasally administered antihistamines and uses thereof
EP3993773A1 (en) * 2019-07-01 2022-05-11 Orion Corporation Methods for administering (r)-n-[4-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)phenyl]acetamide
CA3161960A1 (en) 2019-12-16 2021-06-24 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (ph-hfpef)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
US5688520A (en) * 1995-03-29 1997-11-18 Minnesota Mining And Manufacturing Company Transmucosal delivery of melatonin for prevention of migraine
GB9614098D0 (en) * 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan

Also Published As

Publication number Publication date
HRP20000400B1 (en) 2009-06-30
FI974578A (fi) 1999-06-20
ES2175827T3 (es) 2002-11-16
US6399610B1 (en) 2002-06-04
IL136415A (en) 2005-03-20
NZ504806A (en) 2001-09-28
DE69804678D1 (de) 2002-05-08
FI974578A0 (fi) 1997-12-19
KR100753689B1 (ko) 2007-08-30
RS49889B (sr) 2008-08-07
WO1999032081A1 (en) 1999-07-01
AU738082B2 (en) 2001-09-06
AU1565699A (en) 1999-07-12
JP2001526205A (ja) 2001-12-18
ATE215358T1 (de) 2002-04-15
EA002197B1 (ru) 2002-02-28
SK284838B6 (sk) 2005-12-01
YU36900A (sh) 2003-02-28
KR20010033368A (ko) 2001-04-25
EE200000368A (et) 2001-10-15
EP1052973A1 (en) 2000-11-22
PL191868B1 (pl) 2006-07-31
IL136415A0 (en) 2001-06-14
ZA9811405B (en) 1999-06-11
HU226736B1 (en) 2009-08-28
CA2313618A1 (en) 1999-07-01
HRP20000400A2 (en) 2000-12-31
DE69804678T2 (de) 2002-11-21
EA200000686A1 (ru) 2000-12-25
BR9813641A (pt) 2000-10-17
SK9062000A3 (en) 2000-12-11
NO20003059L (no) 2000-06-14
EP1052973B1 (en) 2002-04-03
CA2313618C (en) 2008-02-05
NO320050B1 (no) 2005-10-17
CZ296693B6 (cs) 2006-05-17
NO20003059D0 (no) 2000-06-14
HUP0100452A2 (hu) 2002-02-28
CZ20002155A3 (cs) 2000-11-15
EE04330B1 (et) 2004-08-16
PT1052973E (pt) 2002-09-30
PL341202A1 (en) 2001-03-26
HUP0100452A3 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
ATE468845T2 (de) Bukkale transmukosale arzneidarreichung unter verwendung einer festen lösung
TR200002855T2 (tr) Raloksifenin solunum yolu ile veya burundan uygulanması.
ATE264102T1 (de) Nicotin enthaltende pharmazeutische zusammensetzungen mit schneller transmukosaler absorption
NO964864D0 (no) Orale, flytende alendronatpreparater
WO1998035658A3 (de) Verwendung von 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzochinon
DK0998287T3 (da) Anvendelse af levobupivacain
DK1052973T3 (da) Transmucosale formuleringer af levosimendan
DK0981347T3 (da) Anvendelsen af levobupivacain i ansigtkirurgi
FI963394A0 (fi) Yskää vastustava koostumus, joka sisältää yskää vastustavaa ainetta ja bentsydamiinia
MD1469G2 (ro) Metodă de tratament al şocului combustional
RU97115801A (ru) Способ лечения стенозирующих ларинготрахеитов у детей
UA41652A (uk) Спосіб лікування хворих на гіпертонічну хворобу
RU98112055A (ru) Способ лечения заболеваний слизистой оболочки рта у больных с вторичными иммунодефицитами
MY117556A (en) Methods and formulations for modulating the human sexual response
UA35918A (uk) Спосіб лікування червоного плескатого лишаю слизової оболонки порожнини рота
UA35948A (uk) Спосіб профілактики уражень слизової оболонки порожнини рота і губ